Skip to main content

FDA Approvals

Novel Assay Provides 100 Times More Information Than Current Liquid Biopsies for Early Cancer Detection

Cediranib-Based Combination Therapy Extends Progression-Free Survival in Relapsed Ovarian Cancer

Dacomitinib Represents Potential New Targeted Therapy for EGFR Mutation–Positive Lung Cancer

Novel Drug “Home Run” for TRK Mutation–Positive Tumors

First FDA-Approved Test to Help Detect Several Leukemias and Lymphomas

First CAR T-Cell Therapy Unanimously Recommended by FDA Advisory Committee for Treatment of B-Cell ALL in Children and Young Adults

FDA Approvals, In the News

Rituximab Combination Now Approved in 3 Blood Cancers

Darzalex Combined with Pomalidomide and Dexamethasone Approved for Relapsed/Refractory Multiple Myeloma

Keytruda First Cancer Drug Approved for Any Solid Tumor Based on a Biomarker Instead of Tumor Site

Imfinzi a New PD-L1 Approved for Bladder Cancer After Platinum-Based Chemotherapy

Page 30 of 53
Results 291 - 300 of 522